A company specializing in the emerging field of nanomedicine has opened in Shelton, offering the possibility that major healthcare advances could be developed in the city. \u201cThe products being produced here could very well end diseases\u201d such as influenza and dengue fever, U.S. Rep. Jim Himes said at this week\u2019s opening of the NanoViricides Inc. facility on Controls Drive. \u201cThis is truly a game changer for humankind,\u201d Himes said. He predicted the company\u2019s president and chairman, Anil R. Diwan, could even win the Nobel Prize in medicine if products now in development at NanoViricides succeed. Diwan said the firm has six medicines in the pipeline that would treat the flu, dengue, HIV, herpes (cold sores) and eye viruses. Moving here from West Haven With money raised from investors, NanoViricides has bought the 18,000-square-foot building at 1 Controls Drive, near Long Hill Cross Road. The company is now moving its facilities and employees there from West Haven. The Shelton site will include manufacturing areas, labs, research-and-development space and offices. The building offers a lot of room for expansion. It will be the only nanomedicine clinical product manufacturing facility in Connecticut. \u201cThis is a big jump for us,\u201d said Diwan, a bioscience researcher, inventor, patent-holder and entrepreneur. He said the company\u2019s scientists \u2014 who mostly hold Ph.D.s like himself \u2014 require lots of room when working on complex problems. \u201cWe need good people with special backgrounds,\u201d Diwan said. While the company only has 15 full-time employees at this time, Diwan said it hires many independent contractors \u201cso our impact is much bigger.\u201d The upside potential also is tremendous, with Himes saying NanoViricides could have 3,000 employees in the future. Diwan said the Shelton facility could \u201chelp foster a pharmaceutical start-up hub in Connecticut.\u201d \u2018Poised for success\u2019 The opening included a luncheon under a tent outdoors, ribbon-cutting ceremony and brief speeches. According to speakers, NanoViricides is involved in \u201cground-breaking medical technologies\u201d and is helping to form the \u201cbackbone of the economy\u201d in Connecticut. Himes \u2014 who Diwan described as \u201cour early supporter\u201d \u2014 and other dignitaries were able to tour the building. Diwan said he\u2019s pleased investors have shown confidence in the firm, and he hopes the company\u2019s research helps humans deal with diseases while also making money. Paul Dorfman of the New York Stock Exchange, where NanoViricides was listed last year, said it was \u201ca company poised for success. Dorfman said he doesn\u2019t expect NanoViricides to remain a small company forever, noting \u201csmall cap companies are about growth.\u201d NanoViricides was founded in 2005 and its market value has gone from $3 million to $250 million, based on its stock price. The company seeks to develop nanomaterials that are capable of specific, multi-targeting of viruses. Commercial potential, economic impact Bill Purcell, Greater Valley Chamber of Commerce president, said many people \u201care bullish on this company.\u201d He said it offers \u201ctrue commercial potential that could have a profound impact on our economy.\u201d Purcell said the Valley has a long tradition of business innovation, dating to the late 1800s and the many manufacturers located in the region. Eugene Seymour, a medical doctor who was involved in introducing rapid HIV blood tests, is CEO of NanoViricides Inc. He recalled Diwan using a pen and napkin to share his ideas for a new company during an initial meeting at a New York City deli a decade ago. \u201cIt\u2019s a very exciting time,\u201d said Seymour, highlighting Connecticut\u2019s role in the field of anti-infectives through the years. The founder's background Diwan was born in India, attended the India Institute of Technology, and later studied chemical engineering in the United States. He became associated with UConn and UMass, and worked for a biotechnologies firm. He invented the technologies licensed to NanoViricides as well as the TheraCour (therapeutic courier) polymeric technologies. Diwan said the reception in Shelton has \u201cbeen just wonderful.\u201d He described Shelton as a pro-business \u201coasis\u201d that has been understanding of his need to have an outdoor generator so the building\u2019s \u201cclean room\u201d can be free of any dirt or dust The building at 1 Controls Drive has been vacant in recent years. It was originally used by OEM Controls and then occupied by a few other companies.